DiscoverThe ExecutiveMatthew Price, Co-Founder & COO of Promontory Therapeutics
Matthew Price, Co-Founder & COO of Promontory Therapeutics

Matthew Price, Co-Founder & COO of Promontory Therapeutics

Update: 2023-08-24
Share

Description


Matthew Price, COO of Promontory Therapeutics is an experienced biotech entrepreneur / C-level executive, and the only company co-founder named a 2022 Emerging Pharma Leader by Pharmaceutical Executive. He is responsible for industry collaborations with Pfizer and Merck KGaA, and for Cooperative Research and Development Agreement (CRADA) with the National Cancer Institute. He previously held research and managerial roles in the NGO and non-profit sectors working in the US and Germany. He holds an AB from Princeton University, and earned his MBA from Columbia Business School, where he was a Chazen Society Fellow in International Business.



Comments 
In Channel
loading
00:00
00:00
x

0.5x

0.8x

1.0x

1.25x

1.5x

2.0x

3.0x

Sleep Timer

Off

End of Episode

5 Minutes

10 Minutes

15 Minutes

30 Minutes

45 Minutes

60 Minutes

120 Minutes

Matthew Price, Co-Founder & COO of Promontory Therapeutics

Matthew Price, Co-Founder & COO of Promontory Therapeutics

Matt Harbert